Our Advantages

  • Access to more than 350 million population in the Middle East and North Africa

  • Flexibility: We support clinical trials by our private clinics, community hospitals or by our network of academic and governmental hospitals

  • Work smoothly with sponsors directly or with CRO’s to compliment any needed services  

Copyright 2004/2018

Avicemer